TrialJectory
TrialJectory59About
What does TrialJectory do?
TrialJectory is an AI-powered decision support platform that democratizes access to advanced cancer treatments. It empowers patients to own their cancer journey by providing instant, personalized lists of cutting-edge treatments matched to their exact diagnosis, free of pharmaceutical bias. The company serves cancer patients by connecting them with treatment options and offers dedicated support from a team of medical professionals.
What is TrialJectory's revenue?
StartupHub estimates TrialJectory's annual revenue at $3.1M (range $1.7M to $4.5M, 66% confidence), based on comparable companies in the sector.
What is TrialJectory's valuation?
StartupHub estimates TrialJectory's effective valuation at $165.9M (range $99.3M to $238.2M, 10% confidence), based on comparable companies in the sector.
How much funding has TrialJectory raised?
TrialJectory has raised a total of $40M in funding. The most recent round on record is Series A.
Where is TrialJectory headquartered?
TrialJectory is headquartered in New York, United States.
When was TrialJectory founded?
TrialJectory was founded in 2017.
What industry does TrialJectory operate in?
TrialJectory operates in Healthcare, Clinical Trials, Cancer, HealthTech, MedTech, Drug Discovery.
How many employees does TrialJectory have?
TrialJectory has approximately 17 people on record.
No comments yet. Be the first to share your take.